Skip to content
    Gates Foundation logo

    Gates Foundation

    Seattle, Washington, United StatesFounded 2000

    The Gates Foundation is a private philanthropic foundation based in Seattle, Washington, focused on fighting poverty, disease, and inequity worldwide. Founded in 2000 by Bill Gates and Melinda French Gates, it is one of the world's largest charitable foundations with an endowment of approximately $89 billion. In May 2025, Bill Gates announced the foundation will close permanently on December 31, 2045, after spending more than $200 billion.

    37% of their portfolio is in Biotech & Life Sciences. Deal activity increased 50% year-over-year (6 deals in the last 12 months). Average disclosed round size is $40.3M (across 28 rounds with reported amounts).

    Find people at Gates Foundation on Goldilocks AI

    Portfolio

    36

    Fund Size

    —

    Top Stage

    Unknown

    Last 12 Mo

    6

    Team

    M. Hari Menon

    M. Hari Menon

    President, Global Growth & Opportunity

    Alex Reid

    Alex Reid

    Chief Communications Officer

    Anita Zaidi

    Anita Zaidi

    President, Gender Equality Division

    Ankur Vora

    Ankur Vora

    Chief Strategy Officer; President, Africa & India Offices

    Ashish Dhawan

    Ashish Dhawan

    Board Member

    Bill Gates

    Bill Gates

    Chair, Board Member

    Carolyn Ainslie

    Carolyn Ainslie

    Chief Financial Officer

    Christopher J. Elias

    Christopher J. Elias

    President, Global Development

    Helene Gayle

    Helene Gayle

    Board Member

    JY

    June Yoshinari Davis

    Chief People Officer

    Kalpana Kochhar

    Kalpana Kochhar

    Interim President, Global Policy & Advocacy Division

    Lauren Bright

    Lauren Bright

    Chief Legal Officer, Corporate Secretary

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    38 investments
    CompanyRoundAmountDate
    Plasmaleap Technologies logoPlasmaleap TechnologiesGrowth—Apr 2026
    Plasmaleap Technologies logoPlasmaleap TechnologiesSeries A$20MMar 2026
    Ten63 logoTen63Unknown—Feb 2026
    Qure.ai logoQure.aiUnknown—Jan 2026
    AAltratechUnknown$441KJan 2026
    Addition Therapeutics logoAddition TherapeuticsUnknown$100MDec 2025
    Nilo Therapeutics logoNilo TherapeuticsSeries A$101MOct 2025
    PunaBio logoPunaBioSeries A—Jul 2025
    Lumen Bioscience logoLumen BioscienceSeries C$30MJul 2025
    Owlstone Medical logoOwlstone MedicalSeries E$27MJan 2025
    SeamlessHR logoSeamlessHRSeries A$9MJan 2025
    Freya Biosciences logoFreya BiosciencesSeries A—Nov 2024
    Noze logoNozeSeed$5MJul 2024
    Kanvas Biosciences logoKanvas BiosciencesSeries A$12.5MJul 2024
    Pula logoPulaSeries B$20MApr 2024
    Bactolife logoBactolifeSeries A—Aug 2023
    SSoapBox LabsUnknown—Jul 2023
    Noze logoNozeSeed$1MMar 2023
    LLumiradxUnknown$14.2MDec 2022
    Eleven Therapeutics logoEleven TherapeuticsSeed$22MAug 2022
    Enko logoEnkoSeries C$70MJul 2022
    SwipeRx logoSwipeRxUnknown$27MMay 2022
    LLeyden LaboratoriesSeries B$40MJan 2022
    Leyden Labs logoLeyden LabsSeries B$140MJan 2022
    EEna RespiratorySeries B—Jan 2021
    Page 1 of 2

    Top Co-Investors

    Last updated: 7 October 2026